Financhill
Buy
54

PNR Quote, Financials, Valuation and Earnings

Last price:
$105.55
Seasonality move :
10.76%
Day range:
$105.21 - $105.93
52-week range:
$74.25 - $113.95
Dividend yield:
0.95%
P/E ratio:
26.74x
P/S ratio:
4.24x
P/B ratio:
4.56x
Volume:
281.6K
Avg. volume:
1.2M
1-year change:
2.96%
Market cap:
$17.2B
Revenue:
$4.1B
EPS (TTM):
$3.94

Earnings Data

Next earnings date for PNR
Feb 03
2026
Most recent earnings per share
$1.12
Missed by $0.06
(Oct 21/2025)
Consensus Estimate
$1.18
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PNR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/03/2026 Q4 $1B -- -- $1.16 --
10/21/2025 Q3 $1B $1B $1.12 $1.18 -$0.06
07/22/2025 Q2 $1.1B $1.1B $0.90 $1.34 -$0.44
04/22/2025 Q1 $988.6M $1B $0.93 $1.01 -$0.08
02/04/2025 Q4 $971M $972.9M $1.00 $1.02 -$0.02
10/22/2024 Q3 $988.4M $993.4M $0.84 $1.07 -$0.24
07/23/2024 Q2 $1.1B $1.1B $1.11 $1.14 -$0.03
04/23/2024 Q1 $1B $1B $0.80 $0.90 -$0.10
01/30/2024 Q4 $975.6M $984.6M $1.25 $0.86 $0.38
10/24/2023 Q3 -- $1B $0.79 -- --
07/27/2023 Q2 -- $1.1B $0.92 -- --
04/27/2023 Q1 -- $1B $0.78 -- --
01/31/2023 Q4 -- $1B $0.58 -- --
10/25/2022 Q3 -- $1.1B $0.70 -- --
07/26/2022 Q2 -- $1.1B $0.92 -- --
04/21/2022 Q1 -- $999.6M $0.71 -- --
02/01/2022 Q4 -- $988.6M $0.89 -- --
10/26/2021 Q3 -- $969.2M $0.86 -- --
07/27/2021 Q2 -- $941.1M $0.79 -- --
04/22/2021 Q1 -- $865.9M $0.77 -- --
01/28/2021 Q4 -- $796M $0.61 -- --
10/20/2020 Q3 -- $798.5M $0.66 -- --
07/23/2020 Q2 -- $713.3M $0.43 -- --
04/30/2020 Q1 -- $710M $0.43 -- --
01/28/2020 Q4 -- $755.2M $0.58 -- --
10/23/2019 Q3 -- $713.6M $0.55 -- --
07/23/2019 Q2 -- $799.5M $0.67 -- --
04/17/2019 Q1 -- $688.9M $0.30 -- --
01/29/2019 Q4 -- $740.5M $0.53 -- --
10/23/2018 Q3 -- $711.4M $0.63 -- --
07/25/2018 Q2 -- $780.6M $0.23 -- --
04/19/2018 Q1 -- $732.6M $0.57 -- --
01/30/2018 Q4 -- $720.8M $1.13 -- --
10/24/2017 Q3 -- $687.6M $0.69 -- --
07/25/2017 Q2 -- $754M $0.34 -- --
04/25/2017 Q1 -- $1.2B $0.48 -- --
01/31/2017 Q4 -- $1.2B $0.71 -- --
10/25/2016 Q3 -- $1.2B $0.76 -- --
07/28/2016 Q2 -- $1.3B $0.78 -- --
04/26/2016 Q1 -- $1.2B $0.59 -- --
02/02/2016 Q4 -- $1.3B -$2.50 -- --

Pentair plc Earnings Questions

  • How Much did Pentair plc Generate in Revenue Last Quarter?

    Pentair plc reported $1B worth of top line sales in its most recent quarter.

  • Did Pentair plc Beat Earnings Last Quarter?

    Pentair plc announced earnings per share of $1.12 which represents a miss of analyst forecast a $1.18 per share.

  • Is Pentair plc Profitable?

    Pentair plc reported $418.6M that represents $2.54 per share over the last quarter.

  • What is the Analyst Consensus for Pentair plc EPS Next Year?

    Pentair plc's earnings are forecast to grow from $3.74 per share to $4.28 per share next year representing an increase of 30.87%.

  • When is Pentair plc's Earnings Date?

    Pentair plc's next earnings date is February 3, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
68
KOD alert for Dec 25

Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.

Buy
64
ZCSH alert for Dec 25

Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock